Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Tumor Tissue and Blood Draw

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · PHASE 4 TRIAL

A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies

ClinicalTrials.gov

This is a recruiting Phase 4 mechanistic study with no results posted; it aims to characterize resistance mechanisms via tissue and blood biomarkers but has not yet generated outcome data.

PreliminaryTumor Tissue and Blood Draw Breast Cancer NCT06274515

Reported

Planned enrollment320

Study phasePhase 4

Primary outcome measure (HER2 coh…Changes from baseline in HER2 protein level…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support